abagovomab 20
abciximab 24
abituzumab 21
abrilumab 13
actoxumab 11
adalimumab 15
aducanumab 8
afasevikumab 11
alacizumab_pegol 8
alemtuzumab 20
alirocumab 10
amatuximab 26
andecaliximab 15
anifrolumab 14
anrukinzumab 16
aprutumab 13
aprutumab_ixadotin 13
arcitumomab 15
ascrinvacumab 4
atezolizumab 14
atinumab 13
avelumab 9
basiliximab 20
bavituximab 23
begelomab 16
benralizumab 17
bevacizumab_beta 18
bezlotoxumab 11
bimagrumab 9
bleselumab 9
blinatumomab 22
blosozumab 27
bococizumab 14
brazikumab 14
brentuximab_vedotin 17
briakinumab 15
brodalumab 7
brolucizumab 25
brontictuzumab 18
burosumab 14
cabiralizumab 19
camrelizumab 9
canakinumab 19
cantuzumab_ravtansin 31
carlumab 12
carotuximab 13
cergutuzumab_amunaleukin2 23
cergutuzumab_amunaleukin 23
certolizumab_pegol 24
cetiximab 30
citatuzumab_bogatox 25
cixutumumab 14
clivatuzumab_tetraxetan 14
codrituzumab 21
conatumumab 9
concizumab 18
crenezumab 14
crizanlizumab 21
crotedumab 18
dacetuzumab 21
daclizumab 10
dalotuzumab 25
dapirolizumab_pegol 19
daratumumab 12
dectrekumab 8
demcizumab 19
denosumab 8
depatuxizumab 15
depatuxizumab_mafodotin 15
dezamizumab 11
dinutuximab 29
diridavumab 16
domagrozumab 12
drozitumab 8
duligotuzumab 19
durvalumab 7
dusigitumab 10
efalizumab 30
efungumab 20
eldelumab 11
elezanumab 13
elgemtumab 9
elotuzumab 10
emactuzumab 15
emapalumab 21
emibetuzumab 13
enavatuzumab 22
enfortumab_vedotin 11
enoblituzumab 15
enokizumab 19
enoticumab 15
ensituximab 17
eptinezumab 12
erenumab 13
etaracizumab 14
etrolizumab 22
evinacumab 16
evolocumab 7
farletuzumab 3
fasinumab 16
fezakinumab 10
fibatuzumab 7
ficlatuzumab 14
firivumab 23
flanvotumab 11
fletikumab 14
foralumab 9
foravirumab 13
fremanezumab 25
fresolimumab 16
fulranumab 18
futuximab 18
galcanezumab 11
ganitumab 19
gantenerumab 7
gemetuzumab 20
gemtuzumab2 18
gemtuzumab 16
gevokizumab 21
girentuximab 20
glembatumumab 14
glembatumumab_vedotin 14
guselkumab 18
ibalizumab 21
ibritumomab 13
icrucumab 8
idarucizumab 21
ifabotuzumab 7
imalumab 14
imgatuzumab 14
inclacumab 15
indatuximab_ravtansin 19
indusatumab 10
inebilizumab 19
intetumumab 6
iodine_girentuximab 27
ipilimumab 0
iratumumab 4
isatuximab 19
itolizumab 22
ixekizumab 22
labetuzumab_govitecan 16
lambrolizumab 23
lampalizumab 20
lanadelumab 18
landogrozumab 15
laprituximab 21
lebrikizumab 23
lendalizumab 21
lenzilumab 14
lifastuzumab_vedotin 24
ligelizumab 19
lilotomab 21
lirilumab 18
lodelcizumab 15
lokivetmab 16
lorvotuzumab_mertansin 13
lucatumumab 26
lumretuzumab 14
lupartumab 12
lutikizumab 15
margetuximab 27
milatuzumab 26
mirvetuximab 21
mirvetuximab_soravtansin 21
modotuximab 31
mogamulizumab 22
monalizumab 16
motavizumab 22
moxetumomab_pasudotox 19
namilumab 16
naratuximab 17
naratuximab_emtansin 17
narnatumab 13
navicixizumab2 21
navicixizumab 21
navivumab 26
necitumumab 7
nemolizumab 18
nesvacumab 11
nivolumab 11
obiltoxaximab 18
obinutuzumab 29
ocaratuzumab 18
ofatumumab 13
olaratumab 14
olokizumab 23
omalizumab 17
onartuzumab 20
ontuxizumab 15
opicinumab 13
orticumab 11
otelixizumab 34
oxelumab 9
ozanezumab 21
pamrevlumab 11
panobacumab 18
parsatuzumab 24
pasotuxizumab 17
pateclizumab 12
patritumab 10
pembrolizumab 23
perakizumab 21
pidilizumab 13
pinatuzumab_vedotin 16
plozalizumab 23
pogalizumab 17
polatuzumab_vedotin 20
ponezumab 24
prezalumab 11
pritoxaximab 22
quilizumab 17
racotumomab 22
radretumab 13
ralpancizumab 19
ramucirumab 11
ranevetmab 23
ranibizumab 18
refanezumab 19
remtolumab 16
rilotumumab 12
rinucumab 13
risankizumab 29
rituximab 13
rivabazumab 13
robatumumab 20
roledumab 21
romosozumab 17
rontalizumab 15
rosmantuzumab 20
rozanolixizumab 17
sacituzumab 21
sacituzumab_govitecan 21
samalizumab 16
sapelizumab 20
sarilumab 15
secukinumab 10
seribantumab 15
setoxaximab 29
sifalimumab 6
siltuximab 17
simtuzumab 18
sirukumab 9
solanezumab 25
solitomab 15
stamulumab 15
suptavumab 19
suvizumab 12
tabalumab 9
tadocizumab 9
tamtuvetmab 25
tanezumab 17
tarextumab 8
tavolixizumab 12
telisotuzumab 19
teplizumab 12
tesidolumab 15
tezepelumab 19
tigatuzumab 14
tildrakizumab 15
timolumab 11
tisotumab 8
tosatoxumab 22
tositumomab 13
tralokinumab 21
trastuzumab 19
tregalizumab 20
trevogrumab 11
ublituximab 16
urelumab 13
ustekinumab 24
utomilumab 21
vadastuximab 18
vadastuximab_talirin 18
vandortuzumab_vedotin 14
vantictumab 12
vanucizumab2 18
vanucizumab 23
varlilumab 13
vatelizumab 17
vedolizumab 15
veltuzumab 4
vesencumab 9
vorsetuzumab 18
vorsetuzumab_mafodotin 18
vunakizumab 25
xentuzumab 15
zatuximab 31
